Smallpox vaccine program evolves
- A New Defense for an Old Enemy. Grauerholz, John // Insight on the News;11/13/2000, Vol. 16 Issue 42, p25
Highlights the efforts of the United States (U.S.) government to prevent the upsurge of global terrorism that uses smallpox agents. Contract of the U.S. Centers for Disease Control and Prevention with Oravax for the production of a smallpox vaccine; History of the use of smallpox as a weapon;...
- Preparing for Patient Zero. Maier, Timothy W. // Insight on the News;12/10/2001, Vol. 17 Issue 46, p18
Reports on the preparations of the U.S. government to counter a possible outbreak of smallpox in the event of a terrorist attack. Opinion of U.S. Health and Human Services Secretary Tommy Thompson on mass inoculation against smallpox; Scenario that would happen in the event of an outbreak;...
- SMALLPOX: LESSONS LEARNED. Hennessey, Timothy P. // Fire Engineering;Jun2003, Vol. 156 Issue 6, p103
Focuses on the request to all military personnel and emergency essential civilian personnel to participate in the smallpox vaccination program in the U.S. Role of the members to patient-care duties; Emphasis on the history of terrorist attacks; Accounts on the possibility of transmitting vaccinia.
- smallpox vaccine. // Royal Society of Medicine: Medicines;2002, p498
The article provides information on a smallpox vaccine which consists of a suspension of live viruses. Smallpox vaccine also works against other poxes and is still used in specialist centres by researchers who work there with dangerous viruses, so need to be immunized. Also, the vaccine is now...
- Update: Adverse Events Following Civilian Smallpox Vaccination--United States, 2003. // MMWR: Morbidity & Mortality Weekly Report;5/9/2003, Vol. 52 Issue 18, p419
Presents updates on vaccine-associated adverse events among civilians following smallpox vaccination administered from January 24 to April 25, 2003 in the United States. Information on possible terrorist attack using smallpox virus; Details of adverse events such as eczema vaccinatum and fetal...
- A Model for a Smallpox-Vaccination Policy. Bozzette, Samuel A.; Boer, Rob; Bhatnagar, Vibha; Brower, Jennifer L.; Keeler, Emmett B.; Morton, Sally C.; Stoto, Michael A. // New England Journal of Medicine;1/30/2003, Vol. 348 Issue 5, p416
Background: The new reality of biologic terrorism and warfare has ignited a debate about whether to reintroduce smallpox vaccination. Methods: We developed scenarios of smallpox attacks and built a stochastic model of outcomes under various control policies. We conducted a systematic literature...
- Smallpox: We'll Soon Have Enough Vaccine... // Child Health Alert;May2002, Vol. 20, p1
Focuses on smallpox vaccine in the U.S.
- Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options. Lane, J. Michael // Annals of Internal Medicine;3/18/2003, Vol. 138 Issue 6, p488
Presents a review of the clinical presentations of major adverse events after smallpox vaccination and the rates of occurrence of these events observed in the 1960s in the United States. Renewed interest in a smallpox vaccination program following reports of a possible terrorist attack using...
- Smallpox Vaccine Adverse Events Among Civilians--United States, February 18-24, 2003. // MMWR: Morbidity & Mortality Weekly Report;2/28/2003, Vol. 52 Issue 8, p156
Summarizes smallpox vaccine-associated adverse events reported among civilians vaccinated in the U.S. as of February 21, 2003. Classification of the adverse events; Provision of the smallpox vaccine to civilian health-care and public health workers; Signs and symptoms of adverse events.